Results 1 to 10 of about 25,127 (239)

Peanut sensitization in a group of allergic Egyptian children [PDF]

open access: yesAllergy, Asthma & Clinical Immunology, 2011
Background There are no published data on peanut sensitization in Egypt and the problem of peanut allergy seems underestimated. We sought to screen for peanut sensitization in a group of atopic Egyptian children in relation to their phenotypic ...
Elham Hossny   +3 more
core   +4 more sources

HLA variation associated with peanut allergy and anaphylaxis among non-Hispanic Black individuals. [PDF]

open access: yesJ Allergy Clin Immunol Glob
Background: Peanut is a major cause of food allergy. HLA genes have been consistently associated with peanut allergy in association studies. To date, however, there have been very few genetic studies of peanut allergy in non-Hispanic Black (Black ...
Wu B   +12 more
europepmc   +2 more sources

Peanut-specific IgG subclasses as biomarkers of peanut allergy in LEAP study participants. [PDF]

open access: yesWorld Allergy Organ J
Antigen-specific IgG2 and IgG3 are rarely measured in food allergy clinical trials despite known function in preventing mast cell and basophil activation.
Baloh CH   +8 more
europepmc   +2 more sources

A new experimental model of peanut allergy in BALB/c and C57BL/6 mice. [PDF]

open access: yesFront Allergy
IntroductionFood allergy protocols are highly variable. While it allows the exploration of multiple scientific questions, it limits the possibility to make general assumptions and point out specific features of allergy to different food allergens ...
Andrade-Oliveira MF   +12 more
europepmc   +2 more sources

Peanut Allergy: An Overview [PDF]

open access: yesAllergy, Asthma & Clinical Immunology, 2008
AbstractPeanut allergies have been increasing in prevalence in most industrialized countries. Onset is typically in early childhood, with a trend towards earlier ages of presentation. The allergy is lifelong in most affected children, although 15-22% will outgrow their peanut allergy, usually before their teenage years. Manifestations of peanut allergy
Al-Ahmed, Nasser   +2 more
openaire   +5 more sources

Long Non-Coding RNAs Expressed in the Peanut Allergy for Understanding the Pathophysiology of Peanut Allergy Rat Model. [PDF]

open access: yesFoods, 2022
Background: Peanut allergy (PA) has become a clinical and public health problem, which is mainly regulated by genetics, immune responses, and environmental factors.
Liu M   +7 more
europepmc   +2 more sources

Assessing pediatric clinician adherence to the guidelines for prevention of peanut allergy: a natural language processing study. [PDF]

open access: yesBMC Med Inform Decis Mak
Background Early introduction of peanut products to infants around 4- to 6- months of age may reduce peanut allergy incidence. However, clinician adherence to the National Institute of Allergy and Infectious Diseases’ 2017 Addendum Guidelines for the ...
Wong AF   +6 more
europepmc   +2 more sources

Development of a mini pig model of peanut allergy. [PDF]

open access: yesFront Allergy
IntroductionThe prevalence of peanut allergies is increasing, emphasizing the need for an animal model to enhance our understanding of peanut allergy pathogenesis and to advance diagnostic tools and therapeutic interventions.
Shakya AK   +7 more
europepmc   +2 more sources

Viral Vector Based Immunotherapy for Peanut Allergy. [PDF]

open access: yesViruses
Food allergy (FA) is estimated to impact up to 10% of the population and is a growing health concern. FA results from a failure in the mucosal immune system to establish or maintain immunological tolerance to innocuous dietary antigens, IgE production ...
Gonzalez-Visiedo M   +6 more
europepmc   +2 more sources

Safety and adherence of early oral immunotherapy for peanut allergy in a primary care setting: a retrospective cross-sectional study. [PDF]

open access: yesAllergy Asthma Clin Immunol
Background Peanut allergy is a common food allergy with potentially life-threatening implications. Early oral immunotherapy for peanut allergy (P-EOIT) has been shown to be effective and safe in research and specialty clinic settings. Provision of P-EOIT
Landry V   +9 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy